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ABSTRACT
Historical sociological research on people with chronic illness has examined their
navigation of their lives post-diagnosis. Diagnosis has been considered with regard, not to
its process, but rather to its definitions.While a rich literature has been produced by such
approaches, how people experience the process of diagnosis has largely been ignored.
This research looks at the process of diagnosis as a series of moments, all of which hold
specific meaning in the interactional context of the patient-provider relationship. Looking
at diagnosis from the patient’s perspective demonstrates how information about health
and illness is exchanged, navigated, and negotiated. Importantly, this research also
reflects that healthcare inequalities, namely those based on race and gender, are intrinsic
to all medical processes. This research outlines the concept of linear and non-linear
diagnostic experiences and the role of power and disempowerment in medical encounters.
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INTRODUCTION
Fans of the popular medical drama “House, M.D.” can tell you: “It’s never lupus”.
And indeed, on “House, M.D.”, only one patient was ever diagnosed with lupus (Kandell
2020). Lupus, specifically, systemic lupus erythematosus (SLE), belongs to a group of
illnesses called autoimmune diseases. Autoimmune disease, and chronic illness in
general, has been included in the sociological eye for a long time, with the clearest
example of this perhaps being Bury’s (1982) study on women with rheumatoid arthritis,
which concluded that disease symptoms transformed into illness experiences that were
disruptive to patients’ identities prior to their diagnosis. Charmaz (1983) unearths a
similar concept and names this “loss of sense of self” as part of the fundamental suffering
of those diagnosed with chronic illness–separate from the physical and manifestations of
the illness. Both of these groundbreaking pieces explored the experiences of people with
chronic illness post-diagnosis. Because sociological literature has focused on illness as a
discrete phenomenon (pre-diagnosis and post-diagnosis), it has missed the experience of
diagnosis itself as an area for rich sociological discovery. This study seeks to begin an
exploration of diagnosis and illness, not as static states, but rather as negotiations of
reality that are constantly in flux.
This paper aims to: 1) establish the process of diagnosis as a sociologically
relevant event that is vital to understanding the experience of people with chronic
illnesses and 2) examine the structure of power and its influence in the interpersonal
dimension of diagnosis. I utilize data from 17 in-depth interviews with women with
chronic illnesses to formulate a model of diagnosis that highlights differences and
1

similarities in diagnostic processes. I also use this data to examine the interactions
between patient and provider and to look at power as a key influence in these
interactions.
In the next pages, I turn to the diagnostic moment, or series of moments, which
lead up to the diagnosis. This process is interactive and it is linked to both individuals and
institutions, with patients and providers both operating as agents with free will, while also
being restricted in their actions and movement by systemic and institutional constraints. I
argue that, at an individual level, the process of diagnosis can be either linear or
non-linear, indicating either a quick and straightforward diagnostic process or, in contrast,
a disorganized and disjointed diagnostic process. Regardless of where participants fell on
this spectrum of diagnosis, there were clear physical and social psychological instances
of extreme suffering. The pain of being dismissed, ignored, or belittled by providers
indicates that, in the relationship between provider and patient, power plays an integral
role in how patients navigate their diagnoses within the medical system. I describe the
means by which providers harness and deploy power in these interactions, and how
patients experience this utilization of power.
In short, this thesis adds to a growing body of literature on the sociology of
diagnosis with empirical examples of how women go through the process of diagnosis.
Secondly, I unravel some of the ways in which power is at play in interactions between
patients and providers. Additionally, I articulate that the understanding of social
characteristics and identities is crucial to understanding how people navigate and
negotiate their diagnoses in medical settings.
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LITERATURE REVIEW
Given the focus of this project on chronic illness and the experience of diagnosis,
I review the relevant literature on: 1) sociology’s insight into chronic illness and
diagnosis, 2) historical and contemporary healthcare inequalities as they relate to chronic
illness and diagnosis, and 3) the cultural health capital framework and its utility for
understanding patient-provider interactions.
SOCIOLOGY OF CHRONIC ILLNESS & OF DIAGNOSIS
As mentioned in the introduction, Bury (1982) and Chamaz (1983)’s qualitative
studies put forth in the 1980s created a fertile ground for improving sociology’s
understanding of illness, specifically chronic illness. We understand chronic illnesses as
existing in separate frameworks from that of temporary illnesses (Bury 1982; Charmaz
1983). Chronic illnesses occupy this unique space precisely because they interrupt our
perception that illness is demarcated by a clear end (Bury 1982; Charmaz 1983).
However, this conceptualization is at odds with the current American medical system,
which attempts to cleanly categorize disease (and associated symptoms and experiences)
as ephemeral states that can be cured in entirety by current medical advances (Bury 1991;
Varul 2020). This brief overview of some historical and contemporary sociological pieces
illustrates the ways in which chronic illness disrupts individual and institutional
expectations. However, despite the sociology of chronic illness being a well-established
subfield, our understanding of the sociology of diagnosis is limited by a lack of empirical
research on the process of diagnosis.
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Despite this limitation, important theoretical pieces contribute to our current
conceptualization of the sociology of diagnosis. It is impossible to decouple chronic
illness and the experience of diagnosis, as diagnosis is the process by which diseases are
categorized and legitimized, or, as Jutel (2009) puts it, “being diagnosed gives permission
to be ill”. Brown (1990) also emphasizes that diagnosis is not a purely objective science;
indeed, social characteristics strongly influence the degree to which diagnoses are
distributed among certain populations, affects the “desirability” of diagnosis, and the
ways in which providers perceive certain diagnoses. Brown (1995) clearly outlines
several typologies of diagnosis, which range from medically legitimized and defined
conditions, medically defined but not-legitimated conditions, medically accepted but not
defined conditions, and conditions neither legitimated nor defined by medicine.
Brown (1995) stresses that diagnosis is not an objective science, but rather a
subjective practice by which medicine and medical providers attempt to organize illness
experiences. Following Jutel’s (2009) and Brown’s (1990) linkage of diagnosis to social
characteristics, the next portion of literature reviewed provides and overview of how
social characteristics play into medical discrimination as well as the assignment of
diagnoses.
HEALTHCARE INEQUALITIES: RACE & GENDER
I focus here on gender and racial inequalities as deeply rooted in Western
medicine. I acknowledge that other identities such as being a part of the LGBTQIA+
community, age, and socioeconomic status all play a role in how one is perceived in
medical settings. However, the research questions, interview questions and the identities
4

present in the sample restrict empirical findings to those based on racial and gender
identities. Therefore, this is not a complete overview of discrimination in medicine, but
rather a focused review on how medical inequalities related to identities present in the
sample originated and persist within the US medical system.
Accounts of “hysterical” women and racist medical abuse such as the Tuskegee
experiment illustrate a fundamental issue with Western medicine: racism and sexism
continue to plague the system of medicine and are continually reproduced through
medical education and medical practices (Washington 2006; Tasca et al. 2012; Paul and
Brooks 2015; Kanaan 2016; O’Brien et al 2020). Understanding that race and gender
cannot be separated from one’s illness experience also indicates that race and gender
cannot be separated from one’s diagnostic experience.
Lorber (1997) articulates that gender, as a socially constructed phenomenon, is
present in all societal structures and the social roles prescribed to men and women may
result in different experiences, even if diagnosed with the same illnesses. Despite
differences in mortality between women and men, women are perceived as “excessive”
utilizers of healthcare while men are perceived as “normal” utilizers of healthcare
(Courtenay 2000). Despite “hysteria” being a diagnosis of the past, women are still more
likely to be given anti-depressants for symptoms with physical causes, while men receive
painkillers (Samulowitz et al. 2018).
Racial disparities in healthcare are also still largely prevalent; racist attitudes
about health insurance status, sexual promiscuity, illegal drug use, and faking illness
affect the interactions between medical providers and people of color (Ross et al. 2012).
Western medicine has also used race as a “genetic” explanation for socially embodied
5

health disparities, such as inequalities in birth mortality rates (Gravlee 2009; Roberts
2015). O’Brien et al. (2020) remind us that race and class are ultimately tied, leading to a
racial gap in access to healthcare in a for-profit healthcare system. In essence, people of
color are discriminated against by a medical system, which then attempts to explain
health inequalities as genetically determined, rather than a result of continuous
discrimination.
Much of sociological literature has been devoted to outlining these inequalities,
particularly in relation to disease distribution, mortality, and healthcare utilization. These
theoretical and empirical findings invite further exploration to understand how exactly
these characteristics emerge in the interactions between patients and providers. In the
next section, I outline the concept of cultural health capital as a rich framework for
looking at interactions in healthcare settings.
THE CULTURAL HEALTH CAPITAL FRAMEWORK: PATIENT & PROVIDER
INTERACTIONS
As one can see in the name of the cultural health capital framework (henceforth
referred to as “CHC”), it relies on the concept of cultural capital as outlined in many of
Bourdieu’s works Shim (2010), one of the founders of the CHC framework, defines
cultural capital as cultural practices and products of all kinds, which are transmitted and
deployed with dominant cultural capital and its deployment resulting in material benefits.
Shim (2010) reminds us that Bourdieu considers cultural capital as something that is
domain dependent, and shifts our focus to the domain of healthcare. The basic tenets of
CHC are that those who possess it demonstrate knowledge of medical topics and
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vocabulary, knowledge of what information is relevant to health care personnel, the skills
to communicate health-related information to providers in a medically intelligible and
efficient manner, an enterprising disposition and a proactive stance toward health, the
ability to take an instrumental attitude toward one’s body, belief in the value of
self-discipline, an orientation toward the future and its control through calculation and
action, a sensitivity to interpersonal dynamics, the ability to adapt one’s interactional
styles, and the ability to communicate social privilege and resources that can act as cues
of favorable social and economic status and consumer savvy (Shim 2010). The laundry
list of that which comprises CHC is a guideline for understanding the interactions that
providers and patients have in this sample.
Several empirical studies have addressed the ways in which CHC operates in
practice. Chang et al. (2016) find that exchange of CHC can mitigate stigma. However,
Chang et al. (2016) note that an improper exchange or failure to recognize cultural health
capital often results in significant diagnostic difficulties. Dubbin et al. (2013) note that
there is a hierarchy to the value of cultural capital and find that differential mobilization
of CHC can contribute to misunderstandings and the propagation of inequalities in
healthcare resulting from the interactions between patient and provider. CHC situates our
perspective of interactions in an “upstream” (rather than “downstream”) location by
accounting for race, gender, and other differences as things that relate back to the degree
of cultural capital held by patients and providers, its disparate deployment, and whether
its exchange is successful or unsuccessful (Dubbin et al. 2013). Therefore, the CHC
framework allows for a deeper understanding of how power is enacted in medical
settings.
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Other theoretical framings relevant to patient-provider interactions are those of
physician expertise, medical uncertainty, and clinician empathy. Taking yet another
interactional approach, Heritage and Maynard (2006) outline the three tenets of the
medical interview used in contemporary medical practice: the psychosocial context of the
patient, the construction of the therapeutic relationship between the patient and physician,
and the education of the patient. Heritage and Maynard (2006) find that physicians who
occupy a paternalistic stance toward patients tend to adopt a more narrowly biomedical
viewpoint with the underlying assumption that the physicians’ interests and the patients’
interests coincide, which can be problematic if those interests do not in fact coincide.
Another key aspect relevant here is the concept of uncertainty. Littlejohn and
Kimport (2017) explore the instantiation of medical uncertainty in relation to
contraceptive care and side effects, noting that uncertainty was often coupled with a
desire to lessen patients’ concerns. In contrast, uncertainty here is conceptualized as a
negative response to the exchange of a patient's CHC. Exploring the experiences of
people with diagnosed autoimmune illnesses will reveal how this uncertainty is
operationalized as a way of disempowering patients during the diagnostic process. In
contrast, Vinson and Underman (2020) bolster the concept of “clinician empathy” as vital
to the success of the patient-provider interaction. All of these concepts are relevant in the
process of diagnosis, as the process of diagnosis is ultimately dialogic, as evidenced by
the CHC framework. The organization of the discourse of medicine, the order of expected
articulations in terms of diagnostic process, and the reliance on the expertise of a
non-empirical science with a historical basis in racism and sexism mean that power
emerges and is operationalized in many different ways (Foucault 1973).
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CLARIFYING DIAGNOSES: UNDERSTANDING PROCESS & POWER
Much of the previous literature on chronic illness and autoimmune disease has
been on how individuals negotiate their lives post-diagnosis. Less well-understood is the
fluid experience of the process of diagnosis. Additionally, this research specifically
examines the role of race and gender in interactions with healthcare providers and within
the healthcare system, which will contribute to the literature on healthcare disparities by
providing concrete examples of the role of patients’ racial and gender identities during
the process of diagnosis. In short, this research aims to explore participant’s experiences
of diagnosis, center such experiences within an interactional framework of
patient-provider interaction, clarify how power works in such a relationship, and assess
the role of race and gender in both the process of diagnosis and the interactions that
precipitate and follow diagnosis.

9

METHODS
I conducted 17 in-depth semi-structured interviews. In these interviews, I asked
women about their experiences being diagnosed with an autoimmune disease, and the
role race and gender played in their process of diagnosis. Participants had to have a
diagnosis of either multiple sclerosis (MS), Crohn’s disease (CD), or systemic lupus
erythematosus (SLE), identify as a woman, be between the ages of 18-60 and reside in
the United States. The sample of participants is a convenience sample. Despite the small
sample, saturation was reached and this data provides relevant information about a
relatively understudied population and phenomenon.
I used social media including Facebook, Instagram, Twitter, Tumblr, Nextdoor,
and Reddit to find participants. I also asked my friends, family, and colleagues to share
the study information with their circles. I conducted these interviews from June of 2021
through August of 2021. Interviews took place on Zoom, a video conferencing platform,
and interview times ranged from 15 minutes up to 60 minutes. For clarity and brevity,
systemic lupus erythematosus is sometimes represented as “lupus” in this paper, Crohn’s
disease as “Crohn’s” and multiple sclerosis as “MS”.
For the interviews, I was in my apartment at the time in Spokane, Washington.
Participants appeared to be in their living spaces as well, though a few participants chose
to attend the interview from their cars. All but one of the participants were located in the
US; one participant was a resident of Canada. Audio and video data were recorded on
Zoom and the audio was transcribed with the help of Temi.com, an automated
transcription service. I edited transcripts for accuracy and clarity. I assigned pseudonyms
10

to every participant. Identifiable locations, institutions, and other persons are redacted in
the data presented in this manuscript. While I am a woman with an autoimmune disease
(though it is not the primary diagnosis of any participants in this study), I did not disclose
this to all participants, electing to share when prompted or when such information seemed
relevant (such as when a participant shared their diagnosis of the same illness I have as
comorbid with their primary diagnosis).
Participants ranged in age from 22 to 43 with an average age of 34. 16 of the 17
participants identified as female. One participant identified as genderqueer, though their
assigned gender at birth was female. The racial and ethnic distribution of the sample was:
2 Black/African American participants, 1 Asian (East Asian/Korean) participant, 1 mixed
race (white and Native American) participant, 1 Arab American participant, and 12 white
participants. White participants had a mixture of European heritages, including
Scotch-Irish, Irish, English, Italian, broadly Mediterranean, Sicilian, German, and Solá
(Catalonian). Figure 1 shows the racial and ethnic make-up of the sample. Figure 1 shows
the racial breakdown of all participants, the participants by illness, and the age range and
average age of participants. Racial labels are derived from participants' self-reports when
asked about race and ethnicity. The figure appears on the following page.
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Figure 1: Racial/ethnic make-up of sample

I used Dedoose to code my interviews. I approached the data using an approach
most in line with the flexible coding approach outlined in Deterding and Waters (2018) as
well as thematic analysis outlined in Braun and Clarke (2006). Looking into the
background literature on the sociology of diagnosis informed the interview questions.
Questions revolved around the diagnosis participants received, their diagnostic story,
their opinions on their providers, and their assessment of how their identities and their
providers' identities influenced their interactions. After collecting the data, I approached
the data in a broad strokes way, making general categories of codes based off of
preliminary readings of the interview data. Broad codes included topical categories such
as “gender” or “race” to identify when respondents were discussing themes. After coding
the data broadly, I began to make the codes within each broad section more granular to
identify the different ways in which the overarching themes appeared. For example,
diagnosis was further divided into “linear”, “non-linear”, and “wildcard” categories. I
then looked at the frequency of the codes to determine what the main analytic
12

cornerstones of this paper were. In line with thematic analysis, I wrote memos relating
codes and interviews to each other. I also checked codes to ensure that they aligned with
the themes I distinguished within the interviews.
I identified several major themes. In this thesis, I zoom in on diagnosis as a
phenomenon distinct from the experience of symptoms or illness and the
operationalization of power within encounters between patients and medical providers.
The themes emerged using different analytical reasoning. The first theme, diagnosis as a
phenomenon, was abductively derived in that the interview questions were guided by a
theoretical literature, but the theme took shape and direction in accordance with the
interviewees’. The second theme, the operationalization of power within the medical
encounter, was derived inductively. The interview questions were not informed by any
literature on power; this theme arose from the answers given in the interviews. While I
had prepared questions to ask specifically about race and gender, and had planned on
using a deductive approach, the themes derived ab-and inductively cannot, at their core,
be separated from the identity of participants. Therefore, I have chosen to weave the
concept of identity throughout my analyses of the process of diagnosis and the concept
of power in the medical sphere rather than taping off a specific section to talk about
identity separately.
First, I look at differences in diagnostic journeys, defining the difference between
and the impact of linear and non-linear diagnostic paths. Then, I examine the role of
power within medical encounters between participants and their providers and establish
how disempowerment and of patients function in the medical sphere. While the explicit
goals noted in the materials for recruitment were related to race and gender in the process
13

of diagnosis, I decided against including a third theme, choosing to integrate findings
about race and gender within the larger framework about the process of diagnosis and the
concept of power and disempowerment. Race and gender are salient to all parts of the
illness experience, and may be explored further, in isolation from the themes discussed
here or integrated, in later pieces to allow adequate space to begin to unpack such
concepts fully.

14

FINDINGS
THE PROCESS OF DIAGNOSIS
The literature on sociology of diagnosis has largely focused on diagnosis as a
categorizing tool for illnesses rather than focusing on the process of diagnosis. This
section examines diagnosis as a range of experiences best understood along a spectrum.
Rather than discussing the myriad ways in which diagnosis organizes illness, I look at the
different manifestations of the diagnostic process as highly varied experiences.
Similarities between diagnostic processes, as well as differences, provide evidence to
organize the range of experiences along a spectrum of non-linear to linear experiences.
Linear diagnoses follow a standard cultural expectation within Western medicine
that one goes to the doctor, receives a diagnosis quickly, and is started on appropriate
treatments in a timely manner. Contrasting this, non-linear diagnoses do not follow this
pattern and are instead characterized by the deployment of uncertainty in the diagnostic
phases of illness, leading to long diagnostic times, misdiagnoses, and inappropriate or
inadequate interventions to cope with illness. I define linear diagnoses with the following
criteria: less than 6 months between first diagnosable symptom and appropriate treatment
(if treatment is sought) and 2 or fewer diagnosing medical professionals encountered
during the diagnostic process (to allow for the possibility of a specialist referral).
The 6 months, like all numbers, is slightly arbitrary. Despite medical tests that
can accurately affirm or disaffirm the presence of autoimmune diseases such as MS, SLE,
and CD, the time to diagnosis is highly variable (UVA Health). Studies on MS suggest a
time frame of around 2 years (Fernández et al. 2010). (Notably, this study is
15

representative of Spain, not the United States). The Lupus Foundation of America
estimates a time frame of 6 years from the first symptom to be diagnosed with SLE
(Lupus Foundation of America). Time to diagnosis for Crohn’s disease is estimated
between 5-9 months, but can be more than 5 years (Fiorino and Danese 2016). (Notably,
this study focuses on European patients). Some delay in diagnosis may be medically
legitimate. However, a study of cancer patients by Miles (2018) finds that patients with a
longer time to diagnosis undergo a higher number of consultations and experience
substandard quality of care. Miles (2018) asserts that the psychological effects of delayed
diagnosis have yet to be fully explored. The harms of delayed diagnosis, as evidenced in
this thesis, can and do pose material and emotional harm to those eventually diagnosed.
In contrast to linear diagnoses, non-linear diagnoses are much more disjointed
and complex, with a wide variety of possible experiences. The unifying trait of non-linear
diagnoses is that they are missing one or both of characteristics that define a linear
diagnosis. Additionally, diagnosis is related to visible physical characteristics, such as
race and gender which influence providers’ perceptions of their patients. Wildcard card
diagnoses are diagnoses that occurred by pure happenstance–which seems like it would
be incredibly rare–but 2 of the participants in this small, qualitative study fit the criteria
for wildcard diagnoses.
The following section outlines how linear experiences function, how non-linear
processes function, the role of identity in the process of diagnosis, and the limits of the
model produced to categorize diagnoses (linear, non-linear, and wildcard diagnoses).
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LINEAR DIAGNOSES
Starting out with linear diagnoses, we can turn to Bessie and Wren’s experiences.
Bessie is a 42 year old white woman who has been diagnosed with MS. Wren is a 22 year
old black woman who has been diagnosed with lupus. When prompted to talk about her
first noticeable symptom, Bessie tells me:
I was having weird sensations in my hand and it didn't go away. And so I went to
a doctor and they said, “no, probably carpal tunnel,” like “wear a wrist thing”.
And so I did that for a little while, and then I went back and I said, “not carpal
tunnel”. And they said, “okay, let's do an MRI”. And said that, that showed
lesions. So we went from low intervention to a big medical test very quickly.
Bessie’s experience highlights perhaps the quintessential linear diagnostic process. She
went into the doctor with a symptom and was given an intervention. While the first
diagnosis and intervention were not the final diagnosis, Bessie articulates how the second
intervention ramped up quickly in intensity, compared to the first intervention. Notably,
the second intervention also contributed to a definite diagnosis of MS, which signifies
that Bessie’s experience of diagnosis is a linear experience. Her experience operates in
the way we expect medicine to operate--symptom, diagnosis, intervention, continued
symptom, escalated intervention, and differential diagnosis all follow in sequential order
and in quick succession. When asked about the total time between her first symptom and
her diagnosis with MS, Bessie tells me that it was likely no more than a couple of months
total.
Another example of the linear diagnostic process is Wren’s experience being
diagnosed with lupus. Wren is a 22 year old Black woman. Wren has the unique
17

experience of having been diagnosed during the COVID-19 pandemic, which she notes
impacted her ability to see doctors due to scheduling demands.
It was around the beginning of like right before COVID started I was working at
Starbucks at the time and I realized like I would wake up in the morning and I'll
be very tired. My hands would be swollen and my feet would be swollen [...] So I
went to a doctor to see what the issue was. And at first he said, I had this thing
called carpal tunnel. [...] So he gave me these pads to wear on my wrist, so my
wrist wouldn’t get swollen anymore. So after a while that didn't work and it was
like my arm symptoms, which is like the fatigue, me getting inflamed was just
getting worse. [...] when I finally did get the appointment with the doctor [...] she
told me that I had lupus.
Wren and Bessie’s experiences are extremely similar, down to the very first diagnosis
and the first intervention given, despite Bessie being diagnosed with MS and Wren being
diagnosed with lupus. When asked about time from her first symptom to a diagnosis of
lupus, Wren tells me that it took about 3 or 4 months, but attributes that wait time to the
delays in care caused by the COVID-19 pandemic. Not all experiences of linear diagnosis
have the exact same symptoms and interventions or even differential diagnoses, but they
all follow the same upshot of an organized experience from symptom to intervention to
diagnosis.
NON-LINEAR DIAGNOSES
In contrast, non-linear experiences of diagnosis are more variable in terms of what
occurs between the first identifiable symptom and the final diagnosis. Generally, patients
who experienced a non-linear diagnostic process have a comparatively long time between
their first identifiable symptom and appropriate medical intervention. Often, they
experience medical care in the form of advice rather than treatment. Aspen, a 31 year old
18

white woman, has experienced symptoms of Crohn’s disease that she identifies as starting
in her childhood, with clear symptoms as early as 4 years old. This portion of her story
picks up 22 years later, when she was 26 and in the emergency room.
The liquid that they give for stomach issues didn’t work. The morphine didn’t
work. I got an emergency [...] CT scan. And they found that not only did I have
that snake pattern ulcer in my lower ileum; it was about 32 centimeters, but my
organs were starting to shut down because the inflammation was so bad
While the time between her emergent symptoms and diagnosis seems short, Aspen
experienced 22 years of uncategorized symptoms. The interventions given by medical
professionals were insufficient, leading to Aspen’s visit to the emergency room, where
sufficient interventions, such as a CT scan, were performed and treatments for Crohn’s
disease were started.
Franziska, a 38 year old white woman with lupus, has a story that also does not
align with the linear expectations of the diagnostic process. Her symptoms began when
she was a teenager and continued into her early twenties before she was diagnosed with
lupus. Franziska recalls that she attempted to see doctors about serious issues multiple
times over the course of many years, only to be repeatedly dismissed.
[The doctors] said nothing was wrong with me and [they were] super mean about
it. So I didn't go back for a really long time, even though they said I should. So
this time I told my doctor, like, “I'd really like you to look again, my ANA has
been positive and I want to make sure that it's not something with that”. So she
ran extra tests and they came back positive again. And she sent me to the
rheumatologist and he did a lot of testing. Like, uh, I want to say like 12 bottles
of blood the first time I went to go see him. And he did find it. He looked hard
enough to find it.
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Aspen and Franziska’s stories demonstrate the disjointed experiences of people with
non-linear diagnostic trajectories. Rather than a clear path from symptom to diagnosis,
they are jostled around in a system for long periods of time, given insufficient or no
answers to their problems, and are generally at a crisis point when receiving their
diagnosis.
WILDCARD DIAGNOSES
There were several diagnostic processes that did not fit into the organizational
schema developed to illustrate the difference between linear and non-linear diagnostic
experiences (dubbed “wildcards”), such as Jane’s experience of being diagnosed with
MS. Jane is a 43 year old white female. Her story begins with symptoms attributed to a
mass in her skull called fibrous dysplasia as well as her history of migraine headaches.
MS was an incidental finding on her imaging for her other neurological conditions. She
tells me about her diagnosis, starting first with the identification of the mass in her skull,
leading into the detection of MS lesions on her brain.
So I ended up going into the [...] neuro-oncology department. [...] The fibrous
dysplasia, the neurosurgeon and the ENT and the face-head-neck surgeon all
recommended that unless, it's hindering my life in some way, keeping me from
working, keeping me from being a mom and a parent and a wife and all of that,
that it's probably best not to do surgery because the likelihood of this mass being
cancer is very, very small.[...] You know, if you don't have to cut into the brain,
you don't want to. [...] and through that process, they did start seeing lesions on
my brain
Jane’s story demonstrates that diagnostic trajectories operate on a spectrum ranging from
non-linear to linear, rather than always fitting neatly within the “linear” or “non-linear”
category, with wildcards falling directly in the halfway point of that spectrum–neither
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classified as linear or non-linear. Her case is unique because she has a low time to
diagnosis, as there is no clear symptom to mark the beginning of the diagnostic process.
There is also a significant medical intervention early on, but again, the lack of an
identifiable symptom confounds this. This type of diagnosis was the least common,
though did occur twice in a relatively small sample of people.
RACE & GENDER IN DIAGNOSIS:
One of the main purposes of this research was to look at gender and race and their
role in the process of diagnosis. Gender and race were generally seen as salient in the
diagnostic process, whether that be in terms of privilege or in discrimination. A rich
literature already outlines the influence of gender and race-based discrimination in
medicine and medical encounters. Here I aim to illustrate how patients view their race
and gender in relation to the process of diagnosis.
Shay, a 38 year old white person with lupus, experienced many years of
symptoms before receiving a lupus diagnosis and treatment. Shay identifies as
genderqueer, though Shay tells me that at doctors’ offices they identify themselves by
their birth gender of female.They fall solidly on the non-linear end of the diagnostic
spectrum. Shay tells me about their other medical issues and starts off by acknowledging
that their skin color and their income resulted in privilege in relationship to diagnosis in
general. However, Shay speculates about race, wondering if their race might have led
doctors to not look as deep into their symptoms.
Interestingly, like, not as much with some of the other stuff like the celiac
and other issues, like if anything being white and moderately well off, I
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got pretty quick access to medical care when I realized something was
going wrong with my body in early 2012. But I--only because you're
asking you in a way, that's making me think about it–I actually had
wondered if, if I had had different colored skin, would my lupus diagnosis
come sooner? Because it is predominantly--more common with women of
color, for example.
Holly, a 26 year old Black woman with lupus, illustrates that Shay’s thoughts on skin
color are a common one in relation to lupus. Holly points out that lupus is a disease that
commonly affects women of color. Despite this, Holly reflects on how race might have
impacted her process of diagnosis. She tells me:
I do think [...] my, my being African-American, it's also a minority heavy
disease as well. And so I think some of the things that I said might, as I'm
getting older, might have been brushed off because of the medical biases
that doctors have against African-Americans and that like, “well, you're
probably making this up.” Or if I explained that my foot is swollen, [...]
that it's obviously not going to turn red because I'm brown. [...] But if you
look at it on somebody who's fair-skinned, you would see that their foot is
swollen and red and obviously see there's something wrong. But looking
at my foot, you just see a fat foot. Whatever they learn in medical school
to look at the skin, there's nothing that would identify that same issue with,
on my skin.
Holly was a participant with a fairly linear diagnostic process, in comparison to
Shay’s non-linear process. Holly, while emphasizing that lupus commonly affects women
of color, points out that other things may have been brushed off due to her race. Similarly,
white patients with MS expressed the same sentiment, but reversed–that their whiteness
helped them receive a quicker diagnosis of MS. Additionally, Holly highlights that
medical education has not provided people of color with the same representation as white
people. The example Holly gives with the swollen foot shows how symptoms can be
dismissed if they are not represented to medical providers in training.
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Both Shay and Holly mention gender in relation to their diagnosis as something
that might have expedited the process of diagnosis. Pearl, a 39 year old Arab American
woman with lupus, also discusses gender in relation to diagnosis. She talks about gender
as a positive thing in terms of getting diagnosed because of the expectation that lupus
primarily affects women. She also talks about the implications of diagnosis for women
outside of the medical environment, such as in the workplace, telling me:
I didn't know this at the time, but I mean, I know that lupus impacts
women nine out of 10 times and that it's generally seen or viewed as a
woman's disease, even though obviously there are plenty of men that get
it. [...] I mean, I was working full time up until my daughter's diagnosis
and newly separated from her father. And I had to take, you know, leave. I
took paid family leave, but then I got diagnosed and there was really no
accommodation made for me [...] You know, people in our society just
don't value us enough and assume that motherhood is just part of our
traditional gender association.
While being a woman might increase the chances that doctors consider lupus as a
diagnosis, Pearl points out that her diagnosis, which coincided with her daughter’s
diagnosis of leukemia, was not taken seriously by her workplace because of the
expectation of women to be caregivers. Many other participants also discussed the role of
parenthood, which may be a topic for further research.
While gender may be seen as an “egg in the diagnosis basket” for many
participants, other participants emphasize that their symptoms and struggles were
downplayed because of their gender, similar to Holly’s experience. While her race may
have expedited the diagnostic process, medical providers still hold biases against women
of color, and medical education is sorely lacking in equal representation. This study looks
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specifically at women and the illnesses I look at are typically perceived as “feminine”
illnesses. They are not generally associated with men. For women, this may be a good
thing as doctors may be more likely to consider their diagnosis. However, coupled with
medical sexism, this benefit may not extend much beyond the initial diagnosis phase.
Additionally, many participants had long times to diagnosis, illustrating that the positive
effect of gender is hazier than expected. Similarly, race appears to benefit patients who
fall into the predicted categories–which for lupus is women of color. Medical providers
must often rely on heuristics in order to function in the current American medical system,
but this can prove detrimental to patients that do not fit the heuristic model of disease for
a specific diagnosis. Further, heuristics easily give into biased thinking patterns that may
explain why so many of the women in this sample experienced sexism in the medical
sphere, even if they had a linear diagnostic process.
THE LIMITS OF THE DIAGNOSTIC SPECTRUM
The spectrum model of diagnostic trajectories is not a perfect categorizing tool,
just as diagnosis itself is not always a perfect categorizing tool. In contrast to the other
participants, Ivy, a 25 year old white woman, was diagnosed with her illness in
childhood. Her dad was the person advocating for her at her doctor’s appointments. She
tells her story starting with when she was an infant experiencing symptoms.
By the time I was two, I got a referral to a GI here [...] And basically my parents
were like, “well, there's family history of Crohn's”. You know, like my uncle had
it really bad and, you know, maybe it's the same thing. And they were like, “well,
she's too young. It usually affects older people”. This is in 1997. [...] Eventually
my dad kind of blocked the door and was like, “look ,” [laughter] “you need to
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do a colonoscopy on her”. So like six months later I got a colonoscopy and they
found out that it was Crohn's. Yeah. That was the start of my journey.
Ivy’s story is different from other participants who were categorized along the spectrum
of linear to non-linear diagnosis. While her symptoms were not met with immediate
intervention, she was diagnosed much earlier than Aspen, who also had symptoms of
Crohn’s disease at a young age. It is difficult to assess why this is–perhaps this was based
on the different doctors encountered by Aspen and Ivy, maybe it was related to the
presentation of their symptoms, or possibly it could have had to do with the leveraging of
power by Ivy’s father (in which he blocks the door and demands testing). Here, I would
argue that the third point is probably the most salient. However, it is hard to characterize
Ivy’s diagnostic process along the same scale as everyone else because she was not the
one advocating for herself or navigating the medical system. The spectrum of diagnostic
experiences developed here is best suited for adults who are in charge of making their
own medical decisions. A different conceptualization may need to be developed for
younger patients or people who are not in charge of making their own medical decisions.
Examining power in the medical encounter brings us to the next theme that
emerged from the data. However, before fully transitioning to the discussion of power in
medicine and in medical encounters, I want to briefly recognize the impact of the
moment of diagnosis. Prior literature on diagnosis makes the assertion that the moment of
diagnosis can be characterized by immense relief. While many participants voiced that a
diagnosis was in a way relieving–an answer to years of unanswered questions and
symptoms–participants also talked about the pain and turmoil caused by a life-long
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diagnosis, regardless of whether their diagnostic process was a linear, non-linear, or
wildcard experience.
The following figure places all participants along the proposed model of the
diagnostic spectrum, to allow for clear visualization of the data. While no definitive
conclusions can be drawn from this small, qualitative study, it is interesting to note that
all participants with Crohn’s disease fall squarely on the non-linear end of the spectrum.
All white participants with lupus also fall on the non-linear end of the spectrum. Gracie,
who is Asian, also falls on the non-linear end of the spectrum despite lupus being
considered, as Holly puts it, a “minority heavy disease” . Wren and Holly, who are Black,
fall into the linear category. Pearl, who is Arab American, also falls into the linear
category for lupus diagnoses. MS had the most variety in where participants fell on the
spectrum with regards to linear, non-linear, or wildcard diagnostic processes.
Figure 2: Participants visualized across the diagnostic spectrum
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POWER & DISEMPOWERMENT:
Diagnosis is related to power, so this section looks particularly at the
operationalization of power enacted by medical providers for the participants in this
sample. I outline how medical encounters in which power is asserted in negative ways
become disempowering experiences for participants, focusing on two main ways that
physicians harness power in negative ways: the utilization of weaponized incompetence
and the deployment of uncertainty. When these tactics are used, patients become
disempowered in seeking the necessary answers to their questions.
Weaponized incompetence occurs in both the private and public spheres.
Typically, weaponized incompetence refers to someone’s significant other (generally a
man in a heterosexual relationship with a woman) who feigns incompetence in order to
avoid responsibility. Additionally, weaponized incompetence means that someone is
capable of performing the task asked of them, and chooses not to–it does not apply to
someone who truly does not know the answers or how to perform a task asked of them. In
this sample of experiences, we see how the deployment of weaponized incompetence can
damage the doctor-patient relationship and disempower patients.
The second way power is operationalized is through the deployment of
uncertainty. This is tied to power and weaponized incompetence because it is ultimately
related to knowledge. The deployment of uncertainty may revolve around symptoms, test
results, or diagnosis. This also serves to disempower patients in that the patient’s reality
is constantly put into question, rather than being validated.
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THE GOD COMPLEX
Weaponized incompetence and the deployment of uncertainty is a tricky subject to
tackle in medicine. On the one hand, it can be easy to rationalize why a medical provider
would not be able to answer a patient’s questions. Medicine and the practice of medicine
has become increasingly divided into specialties and subspecialties. Who would expect
an endocrinologist to be able to treat lung cancer? Likewise, who would expect an
oncologist or pulmonologist to treat polycystic ovarian syndrome? Nevertheless, there is
a, or should be, a basis of expected knowledge. A professional sociologist may not be an
expert in quantitative methods, but they need to have enough knowledge to assess what
types of questions might be answered by a quantitative research study. Likewise, a
primary care provider may not know the answers for a patient who comes in with
autoimmune symptoms, but they should know enough to direct that patient to the person
who can answer those questions. As Holly stated earlier, medical education in the United
States is something that must be examined critically. While some of these participants felt
failed by their providers, it would be irresponsible to wholly assign blame to individuals
when there are systemic mechanisms that also must be considered in tandem with
individuals and their actions.
A 38 year-old white participant with MS, Marianne, shares some poignant
thoughts about power in the medical system with me. Marianne tells me first about her
experience being diagnosed with MS as a completely asymptomatic patient. Her
diagnosis occurred because of the migraines she was experiencing while trying to
conceive a child, resulting in an MRI. When prompted to speak to social characteristics
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that might have played a role in her diagnosis, she elaborates on many things, including
gender biases and white privilege. She tells me her thoughts on medicine, specifically the
field of neurology:
Neurologists also, I think, sometimes, I think--because I have 2 teams of
neurologists--I have a migraine team and then separately I have an MS team, and
both of them, have like--they’re like infertility doctors, in a way, in which they
have a God complex, where they think they’re like, “I have all the newest ideas. I
am, like, the beholder of all the tricks and tips and the new medicines and
everything, and I’m the beholder of knowledge because I’m the MD in the room,
and I’m the one who can fix everything”. And they--they like--each of them are
swollen with power in a different way. And to different degrees.
Here, Marianne identifies a concept that I think is vital in understanding the power
dynamic of weaponized incompetence and uncertainty in medical encounters. Marianne
highlights that the medical gaze is perceived as the ultimate harbinger of truth by society,
which colors medical providers’ perceptions of themselves. It may seem counterintuitive
to suggest that the “God complex” as Marianne names it relates to weaponized
incompetence and the deployment of uncertainty, but this relates to how power is
harnessed by medical professionals. The God complex seems to prop medical providers
up to choose when to apply their knowledge or when to not (deployment of uncertainty)
and how much of their knowledge they are willing to access for a patient (weaponized
incompetence).
WEAPONIZED INCOMPETENCE
The next participant’s experience demonstrates exactly how this harnessing of
power functions when a medical provider utilizes weaponized incompetence. Delia, a 32
year-old white woman with MS, tells me about her experience seeing a non-specialist
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neurologist prior to her appointment with her MS specialist. She tells me that she had an
appointment scheduled with a specialist in MS at this point, but had decided to go to this
appointment with a local neurologist. She tells me:
And so I made an appointment with another neurologist locally who wasn't an MS
specialist and it wasn't a great interaction [...] You know, I presented my negative
MRI [...] and he was like, “well, everything looks fine. So, you know, it looks like
you're fine” And I was like, “well, that's not really all”--at that point again, I had
Googled all the tests that like, you might order for an MS workup, but I hadn't
gone to that appointment yet. And I was like, “well, that's not all that's needed. It's
just MRI. [...] And so like, I corrected him on that and he was like, “well, that's
true”, but didn't show any initiative or interest in ordering them.
Delia’s experience highlights the way in which individual doctors can dismiss or diminish
patient experiences. The doctor says that Delia’s tests look fine, and admits, after
prompting, that the test results really are not enough to come to a conclusive diagnosis.
Delia points out this weaponized incompetence when she talks about the doctor showing
no initiative to order more tests despite acknowledging that more tests needed to be done.
Delia mentions that this is also tied to gender, in that “that first neurologist appointment
[...] he kinda just brushed it off and it's like a young girl who's like going to come in and
have ideas of what her diagnosis is”, which illustrates the intertwined the relationship
between power and gender.
Lorene, a 38 year old white woman with lupus, also points out the ways in which
medical professionals deploy weaponized incompetence as well as the intersection
between gender and the utilization of weaponized incompetence. She tells me about her
experiences seeking medical treatment and also draws on other’s experiences, which she
has heard about through support groups. She tells me:
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They [doctors] automatically think it's hysteria. It's ridiculous, really, because I
have had [to go] to the ER at times for symptoms. No ER doctor wants to touch a
lupus patient. It's too complex for them. It's like, they're all like House. It's either
not lupus or they just don't want to handle it. And so many times I felt crazy until
I would go to my rheumatologist and sure enough, there was something more
severe in the background
Lorene’s story touches on one of the cornerstones of power discussed in this section.
First, she highlights the crux of weaponized incompetence (“it’s too complex for them”).
While the ER may not be the place to get a diagnosis of an autoimmune disease, many
participants ended up either having to go to the ER due to their first symptoms potentially
being life-threatening or due to doctors deploying weaponized incompetence and
diagnostic uncertainty so long that once mild symptoms became potentially
life-threatening. As Lorene points out, much of this has to do with gendered assumptions
about patients. Lorene’s point also leads into the discussion on the deployment of
uncertainty–if a doctor cannot accept or provide a diagnosis (“It’s either not lupus…”),
then what mechanisms do they use in defense to protect their God complex and maintain
their power status?
DEPLOYMENT OF UNCERTAINTY
The deployment of uncertainty is one tactic that was utilized fairly often, as seen
by the long time to diagnosis for many of the patients in this sample. Uncertainty, to some
degree, is just a part of life. It would be unfair to expect doctors to have all the answers
all of the time. However, as was illustrated with the God complex example, many doctors
feel that they do have all the answers. Additionally, uncertainty becomes unacceptable in
instances where it causes detrimental harm to an individual. The deployment of
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uncertainty in medical encounters is insidious because it can be deployed as a method to
make patient’s doubt their experiences and discourage them from seeking out necessary
help. Further, uncertainty in diagnostic terms generally means that the patient does not
receive a “medically valid” diagnosis, which means that they do not get the necessary
treatment until they are at a crisis point, as seen with several participants who took part in
this study.
Chelsea, a 39 year old white and Native American woman, talks about her
experience in the emergency room for urgent symptoms related to MS. She went to a
military hospital late at night due to problems with balance. This was her only
opportunity to go in to the hospital because her husband was at home for the night and
could watch over their 4 young children. The military hospital she visited did not have a
lot of equipment, so they sent her to the hospital in town about an hour out. A CT scan
performed at that hospital indicated that she may be having a stroke, resulting in her
receiving a helicopter lift to the nearest sufficiently equipped medical facility. When
prompted to talk about some of her negative experiences, she tells me:
I mean, when I went into the army hospital, I remember them almost being
angry at me that I would come in. I remember the doctor saying, "why
would you come in at this time?" Like I wasn't inconvenienced to come in
late at night on a Friday. And I just remember thinking like, oh, this is my
only chance. You know, I haven't, I'm not going to bring my four children
four and under, two infants, to sit with me in a hospital. My husband's
gone for weeks at a time, comes home to shower and takes off again. And
I just remember just being angry, especially after I go to the other hospital
and they think I'm having a stroke and I'm thinking they treated me like
this when it was something serious, you know, and they made me feel bad
about wasting their time.
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Chelsea’s experience shows how even in potentially life-threatening situations,
uncertainty can be deployed, though Chelsea’s illness was not truly life-threatening.
Focusing back in on Chelsea’s story, one can see how frustrating the experience was for
her. Chelsea was able to get to the hospital in town and then get airlifted to a bigger
hospital to get diagnosed, but deploying uncertainty, as medical providers so often do,
could have also made Chelsea not pursue treatment. Additionally, the deployment of
uncertainty seems to compound from experience to experience, as seen with the stories of
the next participants.
Nichelle, a 23 year old white woman with Crohn’s disease, talks about how her
diagnosis of Crohn’s disease came about, noting that her doctors are currently
reconsidering the diagnosis based on recent test results. For Nichelle, there was a lot of
uncertainty in the diagnostic process from the beginning onward. She tells me,
I still don't know if this is even related, but I had like a really bad cough
and, um, like burning in my mouth, like anything I would eat [...] so I
went to the urgent care for that [...] The other symptoms, you know, really
weren't that severe yet. [They] told me it was a virus [that] had to run its
course. So for the next couple months, as, you know, losing more weight,
it was progressing. I still thought, you know, I must have some sort of
virus or I really thought I had mono or something. [...] at this point I'd lost
even more weight, um, started out about 95 pounds and I was down 75 and
still just didn't really have an explanation. [...] they admitted me [to the
hospital] right away and I was there for probably around a month. Yeah, so
the first thing they did was an MRI. [...] I needed to have an endoscopy
and colonoscopy to get an official diagnosis
Nichelle’s experience shows us how uncertainty and lack of urgency combine. Her first
diagnoses are vague and the medical providers she saw did not express interest in further
pursuing testing until she reached a crisis point.
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Gracie, a 24 year old Asian woman with lupus, discusses the implications of
uncertainty and the emotional turmoil caused by the deployment of uncertainty (“I felt
like it [the medical system] was failing me”). She tells me about her long time to
diagnosis despite her lab tests indicating lupus for many years prior to her diagnosis,
I think like when you are looking for lupus, there's like a few lab tests that
they can run.And you know, like every single lab test there, a chance that
it's a false positive. What really angered me about all of this is that I've
tested positive for the same test for years. And every time they ran it
they've been positive. So nobody at any point in time thought, “Hmm,
maybe this isn't a fluke that you tested positive, like eight times for the
same thing”. Yet that's exactly how they viewed it every single time. They
were like, “oh, this could be a false positive. We'll just run it again in six
months.” And I'm like, why is this the practice?I've had other experiences
with the medical system, but this is really the first time where I felt like it
was failing me because here I have objective test results, like facts, like
about how sick I am and why. And they were just being overlooked over
and over again, not even by one doctor by like three or four doctors
Gracie’s experience shows us that in spite of objective test results, uncertainty can still be
deployed. She also highlights how this experience is not limited to just one doctor–she
saw many doctors and was dismissed repeatedly. This demonstrates that deployment of
uncertainty is not simply a tactic used by a few select medical professionals. Gracie also
mentions that her gender, age, and race all played a role in her providers’ interactions
with her, with interactions ranging from cloyingly patronizing to overtly racist.
Opal is a 41 year old white woman with MS. Opal’s experience of uncertainty is a
bit different from Nichelle or Gracie’s experiences. Her diagnosis came very quickly
(falling very much on the linear end of the spectrum of diagnosis), but later in her
journey, she was faced with the deployment of uncertainty. This thought actually
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occurred to her post-interview and was sent to me via email. Like Marianne, Lorene,
Nichelle, and Gracie she discusses the impact of gender on the patient-provider
relationship. She writes,
When I met with the middle aged white male (Italian-American)
neurologist who had been recommended to me in Southern Oregon, he
was hesitant to accept that the female neuro in [city] had really checked all
the boxes necessary to give me the diagnosis. He also treated me very
much as a young woman rather than a professional from a different field.
He did accept my diagnosis after obtaining all my previous records and a
new MRI that showed disease progression consistent with MS.
Opal touches on the gendered aspects of the provider-provider relationship as well as the
patient-provider relationship. The male neurologist that Opal saw embodies the God
complex extremely well–he refuses to believe in a diagnosis unless he himself “proves” it
through repeating tests that had already confirmed Opal’s diagnosis. He deploys
uncertainty by casting doubt on the female neurologist’s original diagnosis.
As stated before, the deployment of uncertainty can have different presentations,
but always serves to in some way invalidate the patient’s (or in some cases, the other
physician’s) knowledge. This is problematic, not only in an emotional sense, but also in a
material sense. Pushing people to the crisis point or repeating expensive tests, or doubting
their experiences causes wounds deeper than can be treated by medical professionals.
Several participants expressed that their experiences with the medical system were
incredibly traumatic. Doctors may face wounded pride if the God complex is dismantled,
but that is preferable to the damage that the God complex does to patients.
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THE CONSEQUENCES OF DISEMPOWERMENT
Eileen is a 38 year old white woman with Crohn’s disease. She tells me about her
journey of diagnosis over the past 15 years. She tells me about her perspective on why
her illness took such a long time to be diagnosed by medical providers, noting both
gender as a reason for the lengthy time to diagnosis and acknowledging that the current
US medical system is not set up in a way that helps providers succeed–they are
overworked and underpaid just like many other workers in the US. Eileen’s experience of
diagnosis was a long journey, in which doctors utilized both weaponized incompetence
and the deployment of uncertainty (such as asking Eileen if she thought had Crohn’s
disease, rather than attempting to diagnosis her). She tells me:
When I look back at the way my life has changed since diagnosis, and the ways
that I could have improved my quality of life. I could have been traveling, I could
have been more present for my kids. I could have been a better caregiver for my
husband during his recovery, if I had had a diagnosis and been in treatment, but I
wasn’t. And I didn’t, and it was, like that’s a really hard thing for me to look back
on and I don’t wanna ever regret the way that I’ve lived my life, especially as a
parent or in a relationship, but like...Damn, man, the time that I lost.
Eileen emphasizes the impact that a quick and accurate diagnosis could have had on her
life, and how women can slip through the cracks of a simultaneously discriminatory and
overburdened medical system. Weaponized incompetence and the deployment of
uncertainty mean that people do not get the treatment they need, leading to lost time,
along with the emotional injury of regret, as Eileen mentions. Because of the power
dynamic in medicine, providers have the power to alter significant portions of patients’
lives with their choices. Unfortunately, many providers choose to utilize weaponized
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incompetence and the deployment of uncertainty–both of which have deep and
irreversible consequences on a person’s life and health.
Despite the focus on disempowerment in this section, I want to acknowledge that
almost every participant, when prompted, also shared with me their good experiences
with doctors and medical providers–experiences which I would call empowering. The
common thread of positive experiences involved participants finding doctors who they
felt had high degrees of empathy, who listened to their symptoms, and pursued treatments
in a way that made the participant feel that their doctor was trustworthy and reliable. A
deeper look into power, specifically empowerment, in medical encounters, is likely
necessary to fully understand how power is operationalized within medical settings and
within the patient-provider relationship.
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DISCUSSION
Diagnosis is a fundamental part of the experience of living with chronic illness. In
essence, diagnosis is the process by which diseases are categorized; a disease that is
diagnosed is legitimized (Brown 1995). Jutel (2009) writes “being diagnosed gives
permission to be ill”. Brown (1995) notes that the process of diagnosis is the set of
interactions that lead to the definition of the category. Brown (1995) also articulates how
diagnosis can be a useful ontological tool for both the patient and the physician and this
sentiment is echoed by Jutel (2009), who defines diagnosis as interpretive and
organizational, giving structure to previously unorganized events. Jutel (2009) also
claims a duality of diagnosis; while diagnosis is an organizational tool, it can also be a
site of contestation.
Brown (1995) and Jutel (2009) clarify the importance of diagnostic categories for
both patients and providers. Looking at the process of diagnosis further explores Jutel’s
(2009) concept of a duality of diagnosis. Participants experienced a wide range of
experiences during the diagnostic process, from fairly immediate medical validation to
years of medical doubt and uncertainty. This research supports Brown’s (1995)
framework of diagnosis as a series of interactions between patients and their providers.
The main contribution of this piece to the sociological literature is the exploration
of diagnosis as a process. This expands on previous literature on chronic illness, which
explores biographical disruption (Bury 1982) and loss of sense of self (Charmaz 1983)
post-diagnosis, pivoting to a different moment in the lives of people diagnosed with
chronic illnesses. It builds on the sociology of diagnosis (Brown 1995; Jutel 2009) by
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creating a model in which we might begin to understand the varied processes that
individuals go through when navigating the medical system. It also explores clinician
uncertainty and empathy (Littlejohn and Kimport 2017; Vinson and Underman 2020) and
how the successful exchange of cultural health capital is crucial for patient-provider
interactions (Shim 2010; Dubbin et al. 2013; Chang et al. 2016).
An interactional framework is reminiscent of Heritage and Maynard (2006)’s
outline of the medical interview as a psychosocial phenomenon. Relating to the God
complex, weaponized incompetence, and deployment of uncertainty (Littlejohn and
Kimport 2017) is Heritage and Maynard’s (2006) concept of paternalism, which disrupts
the successful exchange of cultural health capital between patients and providers. As
Chang et al. (2016) remind us, negotiating patient-provider interactions is vital in
stymieing stigma. Underlying the exchange cultural health capital is the need for clinician
empathy, which Vinson and Underman (2020) consider necessary to form positive
relationships between patients and providers.
While racial and gendered healthcare inequalities have been studied extensively
(Lorber 1997; Courtenay 2000; Samulowitz et al. 2018; Ross et al. 2012; Roberts 2015;
Gravlee 2009), this work proves yet again that identities such as race and gender are
intimately tied to diagnostic processes. While gender may have benefited participants at
certain points, gendered inequalities peppered the stories told by participants. Race was
discussed both as a helpful heuristic tool and a harmful heuristic tool. This indicates that
race and gender categorizations may sometimes be neutral characteristics, or even helpful
characteristics, in medical settings. However, instances of medical sexism and racism are
inherently detrimental, not just to the successful exchanging of cultural health capital, but
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to the health and wellbeing of anyone with a chronic illness, and further, are harmful to
all individuals within society.
I consider the key finding of this work to be the diagnostic spectrum. Further
research should focus on categorizing diagnostic processes using these typologies.
Looking into other social characteristics, such as income, English proficiency (in the
context of the US), and other visible or invisible identities, would be an area for further
analysis. It may also be interesting to see how men and gender nonbinary or gender
minority people would be categorized using this spectrum. As stated before, autoimmune
diseases do have a “feminine” reputation–what does that mean for anyone that does not
tick the “female” category? Despite lupus and MS having clear racial distinctions in their
diagnosis, the data illustrates that race may not be a sole determinant of whether someone
has a linear or non-linear diagnostic process. Wildcard diagnoses and their incidence and
psychological impact also strikes me as something to be explored. In short, developing a
framework for different typologies of diagnostic processes was the principal contribution
of this piece and should be analyzed, considered, and evaluated for its utility in the
sociology of diagnosis.
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CONCLUSION
This piece found that women diagnosed with autoimmune diseases have varied
experiences in their journey to receiving a diagnosis. Some experienced quick, linear
diagnostic processes while others experienced drawn-out non-linear diagnostic processes.
Still others were diagnosed by pure chance without any outward physical indication of
disease. Participants understood their race and gender to play a role in their
diagnosis–whether it be a delaying role or an expediting role. In the medical encounters
during, leading up to, or post-diagnosis, participants encountered physicians who used
weaponized incompetence to deny medical care or the deployment of uncertainty to avoid
providing a diagnostic label (despite diagnostic labels bringing significant emotional and
physical relief to participants).
Future research can explore different identities in relation to the diagnostic
spectrum, such as socioeconomic status or language proficiency. As the COVID-19
pandemic continues, future research may also examine the idea of long-haul COVID as a
chronic illness (and test the veracity and reliability of the diagnostic spectrum model in
classifying these patients). This paper focused on people who identified as women, which
means that further research could focus on gender nonbinary or gender minorities,
especially in the context of autoimmune diseases with their “feminine” framing.
Like all studies, this study has several limitations. The sample is a convenience
sample, rather than a representative sample. While conducting the interviews on Zoom
allowed us to transcend geographic boundaries, the sample was still controlled by my
connections and my choice to recruit using social media. The sample is majority white,
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and heteronormative. Recruiting from Reddit means that the participants may have been
more likely to share negative experiences rather than positive experiences, as the
subreddits often function as a sort of support group. This study also only focuses on the
patient side of the patient-provider relationship, so providers are presented through the
words of the patients.
Many of the problems presented in this paper are larger issues in US society, such
as gender and race-based discrimination. Participants point out that medical education
may be an area to improve by changing the curriculum to include images of people of
color within medical textbooks. The healthcare system, as it stands, is not designed to
support complex illness management and while empathy is incredibly important to
patients, teaching empathy is a difficult concept. Doctors, nurses, and other medical
providers are often overworked and underpaid, leaving little time to develop nuanced
relationships and understandings of patients. Neoliberal policies valuing speed, rather
than quality, of care and the middle management of providers through insurance
companies puts providers in difficult situations. Creating fair workplace conditions for
clinicians is vital to moving toward mutual understandings between patients and their
providers. Inequality based on race, class, and gender (as well as other characteristics not
explored here) propagate through stereotypes and lack of education. In conclusion, while
the medical education system and medical system itself continue to perpetuate inequality,
shared understanding between patients and providers will be hard to achieve. While
capitalism continues to value profit over people, everyone within the system, whether
patient or provider, suffers.
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